
U.S. Reps. Contact Medicare in Support of Proposed Changes for 2015 Drug Plans
PRESS RELEASE
ALEXANDRIA, Va. (Feb. 12, 2014) — Members of Congress are contacting the U.S. Centers for Medicare & Medicaid Services (CMS) in support of pro-patient improvements the agency proposed for Medicare Part D prescription drug plans (PDPs) in 2015, a development applauded today by the
In response to
U.S. Representatives Mike Rogers (R-Ala.) and Lynn Westmoreland (R-Ga.) have written to CMS to back the change.
“I was encouraged to hear that the proposed rule for Part D dealt with many of the concerns that [community pharmacists] shared with me,”
Both lawmakers represent rural communities and noted that independent community pharmacies often serve such areas where national chain pharmacies may not exist.
“We commend these lawmakers for voicing their support on behalf of their constituents for the common-sense enhancements that Medicare has proposed for drug plans next year,” said NCPA CEO B. Douglas Hoey, RPh, MBA. “Patients will benefit from more choice and competition among pharmacies if CMS’ proposal is made final. Independent community pharmacies deserve the opportunity to match the contract terms and conditions, including pricing, of ‘preferred’ pharmacies. As Medicare officials have noted, this is ‘the best way to encourage price competition and lower costs in the Part D program.’”
In March 2013, 31 U.S. representatives sent a
While preferred pharmacy networks have been championed by pharmacy benefit managers (PBMs) as producing astronomical cost savings, a
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.